Turn Therapeutics (TTRX) Prepaid Assets (2024 - 2026)

Turn Therapeutics' (TTRX) quarterly Prepaid Assets came in at $235171.0 in Q1 2026, up 95.49% quarter-over-quarter from $120300.0 in Q4 2025.

Turn Therapeutics (TTRX) Prepaid Assets (2024 - 2026) Analysis & Trends

Turn Therapeutics' Prepaid Assets history runs 3 years deep, the most recent figure standing at $235171.0 for Q1 2026.

  • On a quarterly basis, Prepaid Assets changed N/A year-over-year to $235171.0 in Q1 2026; TTM through Mar 2026 was $235171.0, a N/A change from a year earlier, with the FY2025 full-year figure at $120300.0, down 46.61% from the prior year.
  • Prepaid Assets climbed to $235171.0 in Q1 2026 per TTRX's latest filing, from $120300.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $235171.0 in Q1 2026 and bottomed at $120300.0 in Q4 2025.
  • The 3-year median for Prepaid Assets is $206954.0 (2024), against an average of $192344.8.
  • Biggest YoY gain for Prepaid Assets was 46.61% in 2025; the steepest drop was 46.61% in 2025.
  • Year by year, Prepaid Assets stood at $225325.0 in 2024, then sank by 46.61% to $120300.0 in 2025, then jumped by 95.49% to $235171.0 in 2026.
  • Per Business Quant, the three latest TTRX Prepaid Assets figures stand at $235171.0 (Q1 2026), $120300.0 (Q4 2025), and $188583.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Turn Therapeutics 282.39 Mn 282.39 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 235,171.00
Dec 31, 2025 120,300.00
Sep 30, 2025 188,583.00
Dec 31, 2024 225,325.00